Weight management & GLP-1 — built into every plan

Weight Management and GLP-1, With an Evidence Trail

Every clinic can show the prescription. Far fewer can show what happened next. INTENTIQ records screening, consent, titration, review and outcome as connected evidence — not as a folder of PDFs.

Book a Demo

First, the question most clinics get wrong

Clinics adding weight-loss injections often assume they must register with CQC for services in slimming clinics. Frequently, that is not the right activity.

CQC’s scope of registration limits services in slimming clinics to services that prescribe medicines for weight reduction by, or under the supervision of, a registered medical practitioner, delivered at a physical location rather than a remote website service.

Where another healthcare professional — a nurse or pharmacist independent prescriber — treats obesity, it falls instead under treatment of disease, disorder or injury. The same applies where a medical practitioner treats obesity through an online service.

Get the activity wrong and your statement of purpose, your evidence expectations and your inspection route are all misaligned from day one. This is general guidance, not legal advice — confirm your own scope directly with CQC.

The evidence chain

Most systems cover the first four steps well. Inspections are lost on the last three. INTENTIQ records all seven as one connected chain.

1 Screen

Medical questionnaire, healthcare assessment and contraindication screening before anything is prescribed.
2 Consent

A dedicated GLP-1 consent form, branded to your clinic, with risks, alternatives and dose escalation acknowledged.
3 Prescribe

Prescriber, registration number, product, dose and clinical indication recorded against the patient.
4 Dispense

Batch and product traceability, cold-chain protocol and stock deduction at the point of treatment.
5 Titrate

Dose escalation captured as a schedule with review points, and reminders sent by SMS — not left to memory.
6 Review

Named reviewer, dated, with tolerance and side effects recorded and a continue, hold or stop decision.
7 Outcome

Whether the treatment achieved what it was intended to. BMI tracked over time, so progress is evidenced rather than asserted — which is the question an inspector actually asks.

What’s included

Dedicated GLP-1 consent form
Covers tirzepatide (Mounjaro), semaglutide (Wegovy, Ozempic) and liraglutide (Saxenda). Fourteen contraindication checks including MEN 2, thyroid history and pancreatitis, BMI recorded at consent and tracked across the course of treatment, dose-escalation acknowledgement, cold-chain consent and dual patient and clinician signatures.
Purpose-built procedure categories
Weight Management, GLP-1 Injection, IV Therapy, Vitamin Injection and Hormone Therapy — so treatment records map cleanly to evidence categories instead of sitting under a generic label.
Automatic form selection
Select a weight management procedure in the treatment wizard and the correct GLP-1 consent form is presented automatically. No manual searching, no wrong form on file.
Full treatment wizard
Consultation checks and capacity confirmation, before and after photography, AI-assisted clinical notes, stock deduction, prescription logging and aftercare — one guided workflow, one continuous record.
Dose reminders by SMS
Titration only works if the next dose happens on schedule. Reminders go out by SMS, and because messaging is two-way the patient can reply — so a missed dose or a side effect surfaces between appointments instead of at the next review.
The governance spine
Audit framework, safeguarding with a learn, act and review cycle, risk register, training and competency matrix, duty of candour and compliance reporting mapped to CQC Regulations 3–20A.
Isolated per clinic
Multi-tenant by design. Every record, consent form and audit trail belongs to your clinic alone, under your own branding.

Why not generic clinic software?

Most practice management systems bolt on a consent form and call it done. INTENTIQ builds the regulatory pathway into the workflow — from the moment a patient books a GLP-1 consultation through to the effectiveness review months later.

That is the difference between “we have a form” and “we have an evidence trail an inspector can follow.”

See it with your own clinic branding

A short guided demo, no obligation. We will show you the GLP-1 pathway end to end and where your current evidence would sit.

Book a Demo

Or call 0333 043 2226

INTENTIQ supports CQC readiness and helps clinics evidence governance. It does not guarantee registration, licensing or any compliance outcome.

Run the clinic. See the risk. Evidence the quality.